Research Output
Interferon-γ polymorphisms correlate with duration of survival in pancreatic cancer
  Despite progress in diagnosis and staging, pancreatic cancer still has a poor prognosis and it remains difficult to predict duration of survival in advanced pancreatic cancer. Nutritional decline, or cachexia, is a contributory factor to decreased survival in advanced pancreatic carcinoma, and it has been demonstrated that proinflammatory cytokines give rise to cachexia. Interferon (IFN)-γ is a proinflammatory cytokine whose administration increases survival outcomes in a variety of cancers. The human IFN-γ gene has a variable length CA-repeat sequence, the length that has been shown to influence IFN-γ production. The current study was performed to ascertain whether polymorphisms of the IFN-γ gene would influence survival of individuals with advanced pancreatic cancer. The study demonstrated that the presence of allele 2 (12 {CA} repeats) was consistently associated with increased duration of survival after confirmation of nonresectable pancreatic carcinoma. We therefore propose that the presence of allele 2 may be a useful marker for patient outcome.

  • Type:

    Article

  • Date:

    17 November 2004

  • Publication Status:

    Published

  • DOI:

    10.1016/j.humimm.2004.08.184

  • Cross Ref:

    S019888590400607X

  • ISSN:

    0198-8859

  • Library of Congress:

    RC0254 Neoplasms. Tumors. Oncology (including Cancer)

  • Dewey Decimal Classification:

    616 Diseases

Citation

Halma, M., Wheelhouse, N., Barber, M., Powell, J., Fearon, K., & Ross, J. (2004). Interferon-γ polymorphisms correlate with duration of survival in pancreatic cancer. Human Immunology, 65(11), 1405-1408. https://doi.org/10.1016/j.humimm.2004.08.184

Authors

Keywords

Pancreatic cancer, interferon-γ, genetic polymorphisms, prognostic factors,

Monthly Views:

Available Documents